{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:44:46Z","timestamp":1784000686211,"version":"3.55.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The influence of a nonskeletal disease with increased connective tissue synthesis or degradation in the collagen-related markers of bone turnover has been evaluated in 34 women with primary biliary cirrhosis (PBC; age range 41\u201381 years), a disease with increased hepatic fibrosis, often associated with osteoporosis. Serum osteocalcin (BGP), and carboxy-terminal (PICP) and amino-terminal (PINP) propeptides of type I collagen were assessed as indexes of bone formation, whereas serum tartrate-resistant acid phosphatase (TRAP), and cross-linked carboxy-terminal telopeptide of type I collagen (ICTP), and urinary hydroxyproline (HYP), pyridinoline (PYR), deoxypyridinoline (DPYR), and type I collagen cross-linked N- (NTX) and C-telopeptide (CTX) were measured as markers of bone resorption. The histologic stage of the disease and serum amino-terminal propeptide of type III collagen (PIIINP) as an index of liver fibrogenesis were also evaluated. BGP levels were significantly lower, whereas PICP and PINP levels were higher in patients than in controls. Among the bone resorption markers, serum ICTP and urinary PYR, DPYR, HYP, NTX, and CTX levels were significantly higher in patients than in controls. Serum PIIINP levels were also increased in PBC patients. BGP did not correlate with PICP and PINP, but these markers of bone formation as well as ICTP, PYR, DPYR, and NTX correlated with serum PIIINP levels. Serum TRAP did not correlate with collagen-related markers of bone resorption. Moreover, patients with PIIINP and bilirubin above normal levels had higher PICP, PINP, ICTP PYR, DPYR, CTX, and NTX. These markers correlated with the histologic stage of the disease, but not with osteopenia measured by densitometric procedures in 22 patients. In conclusion, collagen-related markers of bone turnover do not reflect bone remodeling in PBC. The close association of these markers with PIIINP and the clinical and histologic stage of the liver disease suggests that they are influenced by liver collagen metabolism.<\/jats:p>","DOI":"10.1359\/jbmr.1998.13.4.731","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:31:28Z","timestamp":1146097888000},"page":"731-738","source":"Crossref","is-referenced-by-count":73,"title":["Collagen-Related Markers of Bone Turnover Reflect the Severity of Liver Fibrosis in Patients with Primary Biliary Cirrhosis"],"prefix":"10.1093","volume":"13","author":[{"given":"Nuria","family":"Gua\u00f1abens","sequence":"first","affiliation":[{"name":"Metabolic Bone Diseases Unit, Hospital Cl\u00ednic i Provincial, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Par\u00e9s","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic i Provincial, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Biochemistry, Hospital Cl\u00ednic i Provincial, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma Jes\u00fas Mart\u00ednez","family":"De Osaba","sequence":"additional","affiliation":[{"name":"Metabolic Bone Diseases Unit, Hospital Cl\u00ednic i Provincial, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Monegal","sequence":"additional","affiliation":[{"name":"Metabolic Bone Diseases Unit, Hospital Cl\u00ednic i Provincial, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Peris","sequence":"additional","affiliation":[{"name":"Metabolic Bone Diseases Unit, Hospital Cl\u00ednic i Provincial, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Ballesta","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Biochemistry, Hospital Cl\u00ednic i Provincial, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Rod\u00e9s","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic i Provincial, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024020713320499400_bib1","first-page":"333","article-title":"Molecular basis and clinical application of biological markers of bone turnover","volume":"17","author":"Calvo","year":"1996","journal-title":"Endocr Rev"},{"key":"2024020713320499400_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0016-5085(82)80291-6","article-title":"Osteoporosis in primary biliary cirrhosis: Effects of 25-hydroxyvitamin D3 treatment","volume":"83","author":"Mattloff","year":"1982","journal-title":"Gastroenterology"},{"key":"2024020713320499400_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0016-5085(82)80292-8","article-title":"Bone disease in primary biliary cirrhosis: Histologic features and response to 25-hydroxyvitamin D","volume":"83","author":"Herlong","year":"1982","journal-title":"Gastroenterology"},{"key":"2024020713320499400_bib4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-103-6-855","article-title":"Bone loss and reduced osteoblast function in primary biliary cirrhosis","volume":"103","author":"Hodgson","year":"1985","journal-title":"Ann Intern Med"},{"key":"2024020713320499400_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-1007365","article-title":"Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis","volume":"13","author":"Lindor","year":"1993","journal-title":"Semin Liver Dis"},{"key":"2024020713320499400_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040452","article-title":"Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins","volume":"10","author":"Schuppan","year":"1990","journal-title":"Semin Liver Dis"},{"key":"2024020713320499400_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI108634","article-title":"Collagen polymorphism in normal and cirrhotic human liver","volume":"59","author":"Seyer","year":"1977","journal-title":"J Clin Invest"},{"key":"2024020713320499400_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Path Anat Histol"},{"key":"2024020713320499400_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01623782","article-title":"Guidelines for diagnosis and management of osteoporosis","volume":"7","author":"Kanis","year":"1997","journal-title":"Osteoporos Int"},{"key":"2024020713320499400_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1530-0277.1984.tb05684.x","article-title":"Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease","volume":"8","author":"Savolainen","year":"1984","journal-title":"Alcohol: Clin Exp Res"},{"key":"2024020713320499400_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hep.1840050109","article-title":"A radioimmunoassay procedure for type III procollagen: Its use in the detection of hepatic fibrosis","volume":"5","author":"Galambos","year":"1985","journal-title":"Hepatology"},{"key":"2024020713320499400_bib12","first-page":"111","article-title":"El p\u00e9ptido aminoterminal del procol\u00e1geno tipo III como \u00edndice de fibrosis hep\u00e1tica en los alcoh\u00f3licos cr\u00f3nicos","volume":"9","author":"Torres","year":"1986","journal-title":"Gastroenterol Hepatol"},{"key":"2024020713320499400_bib13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/0016-5085(86)90391-4","article-title":"Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis","volume":"90","author":"Torres","year":"1986","journal-title":"Gastroenterology"},{"key":"2024020713320499400_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0168-8278(86)80048-4","article-title":"The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis","volume":"2","author":"Ericksson","year":"1986","journal-title":"J Hepatol"},{"key":"2024020713320499400_bib15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(88)91843-0","article-title":"Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis","volume":"1","author":"Babbs","year":"1988","journal-title":"Lancet"},{"key":"2024020713320499400_bib16","first-page":"109","article-title":"El p\u00e9ptido aminoterminal del procol\u00e1geno tipo III en la cirrosis biliar primaria. Significado cl\u00ednico y valor pron\u00f3stico","volume":"12","author":"Salmer\u00f3n","year":"1989","journal-title":"Gastroenterol Hepatol"},{"key":"2024020713320499400_bib17","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/0024-3205(82)90023-6","article-title":"Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis","volume":"30","author":"Maruyama","year":"1982","journal-title":"Life Sci"},{"issue":"Suppl 2","key":"2024020713320499400_bib18","first-page":"43","article-title":"Collagenases and liver fibrosis","volume":"22","author":"Arthur","year":"1995","journal-title":"J Hepatol"},{"key":"2024020713320499400_bib19","first-page":"1356","article-title":"Factors influencing the development of metabolic bone disease in primary biliary cirrhosis","volume":"85","author":"Gua\u00f1abens","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"2024020713320499400_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hep.1840070127","article-title":"Low bone turnover state in primary biliary cirrhosis","volume":"7","author":"Stellon","year":"1987","journal-title":"Hepatology"},{"key":"2024020713320499400_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2710345","article-title":"Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells","volume":"271","author":"Smedsrod","year":"1990","journal-title":"Biochem J"},{"key":"2024020713320499400_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.179.2.405","article-title":"Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells","volume":"179","author":"Melkko","year":"1994","journal-title":"J Exp Med"},{"key":"2024020713320499400_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinchem\/36.3.421","article-title":"Radioimmunoassays of type I collagen that mainly detects degradation products in serum: Application to patients with liver diseases","volume":"36","author":"Hartmann","year":"1990","journal-title":"Clin Chem"},{"key":"2024020713320499400_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0676.1994.tb00085.x","article-title":"Serum markers of hepatic fibrogenesis in chronic hepatitis C treated with alfa-2 interferon","volume":"14","author":"Gallouni","year":"1994","journal-title":"Liver"},{"key":"2024020713320499400_bib25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/clinchem\/33.4.458","article-title":"Characterization and assay of tartrate-resistant acid phosphatase activity in serum: Potential use to assess bone resorption","volume":"33","author":"Lau","year":"1987","journal-title":"Clin Chem"},{"key":"2024020713320499400_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00308325","article-title":"Serum tartrate-resistant acid phosphatase (TRAP) as biochemical marker of bone remodeling","volume":"52","author":"Rico","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"2024020713320499400_bib27","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/jbmr.5650111011","article-title":"Tartrate-resistant acid phosphatase from human bone: Purification and development of an immunoassay","volume":"11","author":"Halleen","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024020713320499400_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840040101","article-title":"Bone disease in primary biliary cirrhosis: Increased bone resorption and turnover in the absence of osteoporosis or osteomalacia","volume":"4","author":"Cuthbert","year":"1984","journal-title":"Hepatology"},{"key":"2024020713320499400_bib29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/8756-3282(93)90310-7","article-title":"Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis","volume":"14","author":"Hodgson","year":"1993","journal-title":"Bone"},{"key":"2024020713320499400_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0169-6009(91)90143-N","article-title":"Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease","volume":"8","author":"Uebelhart","year":"1990","journal-title":"Bone Miner"},{"key":"2024020713320499400_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jbmr.5650060615","article-title":"Urinary excretion of pyridinoline correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis","volume":"6","author":"Delmas","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2024020713320499400_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1359\/jbmr.1997.12.1.59","article-title":"Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis","volume":"12","author":"Eastell","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"Suppl 266","key":"2024020713320499400_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/17453679509157685","article-title":"The specificity of collagen cross-links as markers of bone and connective tissue degradation","volume":"66","author":"Eyre","year":"1995","journal-title":"Acta Orthop Scand"},{"key":"2024020713320499400_bib34","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0168-8278(96)80265-0","article-title":"Pyridinoline collagen cross-links in patients with chronic viral hepatitis and cirrhosis","volume":"24","author":"Hayasaka","year":"1996","journal-title":"J Hepatol"},{"key":"2024020713320499400_bib35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840150408","article-title":"Hydroxypyridium collagen cross-links in human liver fibrosis: Study of alveolar echinococcosis","volume":"15","author":"Ricard-Blum","year":"1992","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"2024020713320499400_bib36","first-page":"S287","article-title":"Biochemical markers of bone metabolism are affected by non-skeletal diseases involving collagen turnover","volume":"8","author":"Seibel","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024020713320499400_bib37","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","article-title":"A specific immunoassay for monitoring bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine","volume":"7","author":"Hanson","year":"1992","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"2024020713320499400_bib38","first-page":"S178","article-title":"A rapid method for quantifying osteoclast activity in vitro","volume":"9","author":"Apone","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024020713320499400_bib39","first-page":"1693","article-title":"Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment","volume":"79","author":"Garnero","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713320499400_bib40","first-page":"780","article-title":"Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease","volume":"79","author":"Garnero","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713320499400_bib41","first-page":"864","article-title":"Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment","volume":"80","author":"Bonde","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713320499400_bib42","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1359\/jbmr.1997.12.7.1028","article-title":"Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen","volume":"12","author":"Bonde","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024020713320499400_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0016-5085(97)70098-2","article-title":"Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: Preliminary results after two years","volume":"113","author":"Gua\u00f1abens","year":"1997","journal-title":"Gastroenterology"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.1998.13.4.731","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/13\/4\/731\/56598396\/5650130421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/13\/4\/731\/56598396\/5650130421.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:56:33Z","timestamp":1710341793000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/13\/4\/731-738\/7514431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4,1]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[1998,4,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.1998.13.4.731","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1998,4,1]]},"published":{"date-parts":[[1998,4,1]]}}}